1 / 22

Phospholipids, Phosphoinositols & Eicosanoids

Phospholipids, Phosphoinositols & Eicosanoids. Phospholipids, Phosphoinositols & Eicosanoids. Common types of Phospholipids:. Phospholipids, Phosphoinositols & Eicosanoids. Second messenger released through hydrolysis by phospholipases and/or

tristessa
Download Presentation

Phospholipids, Phosphoinositols & Eicosanoids

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Phospholipids, Phosphoinositols & Eicosanoids

  2. Phospholipids, Phosphoinositols & Eicosanoids Common types ofPhospholipids:

  3. Phospholipids, Phosphoinositols & Eicosanoids Second messenger • released through hydrolysis by phospholipases and/or • generated through the actions of lipid kinases Phospholipases: Phosphatidylinositol-kinases:

  4. Phospholipids, Phosphoinositols & Eicosanoids Phospholipases: • PLA2: • Cytoplasmic form (90 kDa) is regulated through nM Ca++ (Annexins) and phosphorylation; AA specific => signaling function • Secreted form (pancreas, 14 kDa) is also Ca++ dependent (mM range)=> digestive function • PLC: coupled to a variety of (growth factor) receptors: • PLC is activated through GPCRs (Gq) => binding enhances its catalytic activity and in return the GTPase activity of Gq (similar to GAP function in ras signaling) • PLC couples with its SH2 domains directly to growth factor receptors (EGFR, PDGFR) or the TCR, where it is activated through tyrosine phosphorylation

  5. Phospholipids, Phosphoinositols & Eicosanoids Both phospholipases yield finally arachidonic acid (see below), in addition, PLC activity also produces DAG and IP3: • DAG: remains membrane bound; diacylglycerol kinase phosphorylates DAG to generate phosphatidic acid which functions as a substrate for PLA2. Phosphatidyl-serine (PS), Ca++ and DAG activate PKC on the plasma membrane • IP3: see Ca++ signaling!! • Glucocorticoids: inhibit PLA2 by transcriptionally inducing Lipocortin, a protein which binds to PLA2 and blocks its activity. • Phorbol esters: strongest known tumor promotors; mimic DAG => bind PKC and activate it. Also potent activator of Ca2+ influx, MAPK pathway etc.

  6. Phospholipids, Phosphoinositols & Eicosanoids Lipid kinases: • PI3-kinase: • binds to and becomes tyrosine phosphorylated in response to activation of growth factor receptors or immune receptors • 85 kDa regulatory subunit (pY) and a 110 kDa catalytic subunit • regulatory subunit contains SH2 and SH3 domains • PIP3-phosphates can bind to the pleckstrin homology (PH) domain of Akt => Akt activation => phosphorylation of BAD, which dissociates from the antiapoptotic protein bcl-2 => inhibition of apoptosis • Wortmannin: fungal metabolite, potent, irreversible inhibitor of PI3Kinase • Ly290004: synthetic compound, blocks ATP binding site of PI3Kinase

  7. Arachidonic Acid Metabolism • Eicosanoids: collective name for derivatives of arachidonic acid (=5,8,11,14 - eicosatetraenic acid) • AA is mainly generated through the action of PLA2 and DAG-lipase. • Rapidly metabolized by cyclooxygenase and lipoxygenase into prostaglandins and leukotrienes:

  8. Arachidonic Acid Metabolism • Prostaglandins: • First observed in seminal fluid => name • Structure of cyclopentane ring defines letter • Double bonds in side chains account for number • Greek letter refers to the spatial position of the OH-group at C-9 Initial step in PG synthesis catalyzed by PGH-synthase which has dual enzymatic activity: cyclooxygenase (closes ring =>PGG2) and peroxidase (=> 15-OH)

  9. Arachidonic Acid Metabolism Biological functions of PGs: • Vascular toneRelaxation: PGs E1, E2, F2 and I2 Constriction: PGs F2, TxA2 • Platelet aggregationIncrease: PGs E1, TxA2 Decrease: PGs E2, I2 • Uterus toneIncrease: PGs E1, E2, F1 • Bronchial muscleConstriction: PGFs Relaxation: PGEs • Gastric secretionInhibition: PGs E1, E2, I2 • Temperature and painIncrease: PGEs

  10. Arachidonic Acid Metabolism • Leukotrienes: • First found in leucocytes; contain 3 conjugated double bonds • Lipoxygenase generates Hydroperoxyeicosatetraenoic acid (HPETE) • LTC4, D4 and E4 mediate allergic reaction: Slow Reacting Substance of Anaphylaxis (SRS-A) => mediates anaphylactic shock 10,000 fold more potent than histamine!!! => constricts bronchi, dilate blood vessels • LTB4 is a very strong chemoattractant for macrophages

  11. Growth Factor Receptors • Many growth factors (EGF, PDGF, IGF-1, CSF-1, ...) signal through receptors withintrinsic tyrosine kinase activity • Common features: • Large, glycosylated ligand binding domain • Single hydrophobic transmembrane domain • Activation occurs through ligand mediated oligomerization • Undergo ligand induced downregulation by internalization • Cytoplasmic tyrosine kinase domain: • most highly conserved region • GlyXGlyXXGlyX(15-20)Lys Lys is critical for ATP binding - mutation renders receptor kinase inactive, which abrogates all cellular responses => signaling depends on tyrosine phosphorylation of receptor and cytoplasmic substrates • Tyrosine kinase receptors also bind and activate cytoplasmic tyrosine kinases • Autophosphorylation sites: • conserved in the C-term of each receptor class • autophosphorylation does not effect Km of receptor kinase activity • provide docking sites for SH2 domain containg signaling proteins

  12. Growth Factor Receptors • Three subclasses: • Class I: two Cys-rich region in the EC, monomeric ligand EGF-R, erbB2, erbB3, erbB4 (heregulin receptors) • Class II: heterotetrameric: 2  and 2  chains stabilized through S-S bonds: monomeric ligand Insulin-R, IGF-1-R • Class III: Repeats of mmunoglobulin-like structure, dimeric ligand FGF-R, NGF-R, PDGF-R, CSF-1-R, c-kit

  13. Growth Factor Receptors Signaling through Adapter proteins: • grb2: adapter with one SH2 domain which binds PY residue on RTK, and two SH3 domains which bind to • Sos: “Son of Sevenless” (mutation in drosophila prevents development of the R7 photoreceptor cell). Functions as a GEF to facilitate GTP loading of • ras: GTP binding protein, farnesylated; protooncogene, provides a docking site on the plasma membrane for raf. • ras-GAP: negative regulator of groth factor signaling: promotes GTP hydrolysis through the GTPase activity of ras.

  14. Growth Factor Receptors Signaling through Adapter proteins: • raf: ser/thr kinase of the MAPKKK/MEKK family (MEKK does normally NOT phosphorylate MEK, but rather MKK4/7 => Stress pathway); requires context of plasma membrane for activation (mixing GTP-ras and raf in a test tube fails to activate raf) => raf likely to be phosphorylated at the plasma membrane. Activated raf phosphorylates... • MEK: Dual specificity kinase (in case of Stress pathway: SEK) phosphorylates ERKs or MAPKs on tyr and thr -> • ERKs: migrate to the nucleus where they phosphorylate transcription factors such as fos and jun; also feedback loop to other signaling molecules

  15. Growth Factor Receptors

  16. CytokineReceptors • “Classical” hormones: • produced by cells organized into endocrine organs, • often referred to as “endocrine signal molecules” • target cells usually distant from the site of synthesis • hormone carried by blood stream from producing gland to target cells • signal through receptors coupled to G-proteins (e.g. epinephrine receptor), ion-channels • (e.g. acetylcholine receptor) or receptors with intrinsic enzymatic activity • Cytokines: • single producing and effector cell • only affect target cells in close proximity (autocrine or paracrine) • almost exclusively involved in regulating immunological processes • sometimes subdivided into different groups based on their origin (lymphokines, monokines, interleukines) • often carry several (old) names based on their multiple biological functions: e.g. Lymphocyte Activating Factor (LAF) = Mitogenic Protein (MP) = T Cell Replacing Factor III (TRF-III) = B Cell Activating Factor (BAF) = B cell Differentiation Factor (BDF) = INTERLEUKIN 1

  17. CytokineReceptors • Basic characteristics: • only one copy of encoding gene per haploid cell (~20 different IFN’s, but each encoded by a distinct gene) • genes segmented into 4 or 5 exons (exceptions are IFN and IFN: no introns) • mature protein usually between 8 and 25 kDa • barely any structural resemblances • often N-glycosylated • often form oligomers • some carry signal sequence in precursor • expression is tightly regulated on a transcriptional level • generally pleiotropic • usually highly species specific (up and down) • Multiple (old) classifications: • Based on origin (Lymphokines, Monokines..) • Based on action (inhibitory, stimulating, antiviral, chemotactic...) • Based on composition of receptor (single-chain vs. multi-chain)

  18. CytokineReceptors • Current nomenclature based on structure of receptors: • Type I cytokine receptors = hematopoietin receptor family:receptors contain W-S-X-W-S motif in the C-terminus • IL-2 R, IL-3 R, IL-4 R, IL-5 R, IL-6 R (has also Ig-like domain), IL-7 R, IL-9 R, IL-11 R IL-13 R, IL-15 R, GM-CSF R, EPO R, G-CSF R (has also Ig-like domain) • Type II cytokine receptors = Interferon receptor family:receptors contain IRH1 (200aa extracellular) and IRH2 (50 aa cytoplasmic) domain • IFN R, IFN R • Type III cytokine receptors = TNF receptor family: receptors contain 4 Cys rich regions in extracellular domain • TNF R, TNF=LT R, NGF R (trk), fas, CD40 • Type IV cytokine receptors = Immunoglobulin family: receptors contain an Ig like repeat in the extracellular domain • IL-1 R, M-CSF R (c-fms), SCF R = steel factor R (kit) (tyrosine kinase activity), (IL-6 R) (has also W-S-X-W-S motif), (G-CSF R) • (Chemokine receptors): • C-X-C subgroup (-family): IL-8, PF4, TG • C-C subgroup (-family): RANTES, MCAF, MIP-1

  19. CytokineReceptors Signal Transduction: Receptors lack intrinsic catalytic activity but associate w/ cytosolic enzymes STAT: Signal transducer and activator of transcription • contain SH2 domains • become tyrosine phosphorylated after stimulation • 6 family members • homo or heterodimerize • translocate to nucleus and bind enhancers JAK: Janus kinase • large cytoplasmic tyrosine kinases (130-140 kDa) • NO SH2 or SH3 domains • kinase-like domain

  20. Ser/Thr-kinaseReceptors Transforming Growth Factors = TGFs: • Murine sarcoma virus infected cells can not bind EGF => cells produce a growth factor that competes for EGF binding (=sarcoma growth factor, SGF). • SGF promoted anchorage independent growth (reversible) => first evidence that transformed cells produce their own growth factor! • SGF was found to consist of two subunits: TGF: EGF competitor, binds and signals through the EGF receptor, potent mitogen, but does not support anchorage-independent growth overexpressed in epithelium of psoriasis patients (=> hyperproliferation of keratinocytes) • TGF: acts through distinct receptor, it also is a potent mitogen, but it also does not support anchorage-independent growth (only combination does!) TGF- receptors I and II: • external ligand binding domain and cytosolic serine/threonine kinase activity. • betaglycan: proteoglycan required for TGF binding

  21. Ser/Thr-kinaseReceptors Signal Transduction: SMADs: • 8 members - conserved MH1 and MH2 domain • rapidly phosphorylated in response to TGF (2,3) or BMP (1,5,8) • Smads function in heteromeric complexes • “common” Smad = Smad-4 (Smad-4 required for all Smad signaling) • translocate to the nucleus • phosphorylated by the receptor itself • phosphorylation motif: SSXS • Smad1 potentially also activated by MAPK • Mutations of Smads and /or TGFR are found in 90% of colon cancers

  22. NFkB • originally identified as a transcription factor binding an enhancer (B)in the -light chain immunoglobulin gene • Activated by a variety of (proinflammatory) signals (IL-1, TNF, Phorbol esters...) • Homo-or heterodimer composed of p50 and/or p65 subunits • retained in its inactive form in the cytoplasm by the inhibitory protein IB • dissociation of NFB from IB activates NFB’s DNA binding capabilities • NFB/ IB association is regulated by serine phosphorylation of IB! • Phosphorylated IB does not dissociate from NFB, rather is marked for degradation (NFB activation can be inhibited by protease inhibitors!) • Phosphorylation of IB through IB-kinase (complex >600 kDa) • IKK: two kinase subunits: IKK and IKK homo- or heterodimers IKK (NEMO): no kinase activity, required for complex assembly = regulatory subunit

More Related